Cargando…

Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care

BACKGROUND: There is accumulating evidence for an increased cardiovascular burden in inflammatory arthritis, but the true magnitude of this cardiovascular burden is still debated. We sought to determine the prevalence rate of non-fatal cardiovascular disease (CVD) in inflammatory arthritis, diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nielen, Markus MJ, van Sijl, Alper M, Peters, Mike JL, Verheij, Robert A, Schellevis, François G, Nurmohamed, Michael T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493278/ https://www.ncbi.nlm.nih.gov/pubmed/22906083 http://dx.doi.org/10.1186/1471-2474-13-150

Ejemplares similares

Increased risk for chronic comorbid disorders in patients with inflammatory arthritis: a population based study
por: Ursum, Jennie, et al.
Publicado: (2013)

Inter-practice variation in diagnosing hypertension and diabetes mellitus: a cross-sectional study in general practice
por: Nielen, Markus MJ, et al.
Publicado: (2009)

The validity of the diagnosis of inflammatory arthritis in a large population-based primary care database
por: Nielen, Markus MJ, et al.
Publicado: (2013)

Effect of anti-inflammatory therapy on vascular biomarkers for subclinical cardiovascular disease in rheumatoid arthritis patients
por: Blanken, Annelies B., et al.
Publicado: (2022)

Confounding by Indication Probably Distorts the Relationship between Steroid Use and Cardiovascular Disease in Rheumatoid Arthritis: Results from a Prospective Cohort Study
por: van Sijl, Alper M., et al.
Publicado: (2014)

The usefulness of a free self-test for screening albuminuria in the general population: a cross-sectional survey
por: Nielen, Markus MJ, et al.
Publicado: (2009)

Cardiovascular risk management in rheumatoid arthritis: are we still waiting for the first step?
por: Peters, Mike JL, et al.
Publicado: (2013)

Increased incidence of kidney diseases in general practice after a nationwide albuminuria self-test program
por: de Borst, Julia, et al.
Publicado: (2011)

Arterial wall inflammation is increased in rheumatoid arthritis compared with osteoarthritis, as a marker of early atherosclerosis
por: Agca, Rabia, et al.
Publicado: (2021)

Cardiovascular risk management in patients with active Ankylosing Spondylitis: a detailed evaluation
por: Heslinga, Sjoerd C, et al.
Publicado: (2015)

Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout
por: Hansildaar, Romy, et al.
Publicado: (2021)

Calculating incidence rates and prevalence proportions: not as simple as it seems
por: Spronk, Inge, et al.
Publicado: (2019)

Unresolved Questions in Rheumatology: Motion for Debate: The Data Support Evidence-Based Management Recommendations for Cardiovascular Disease in Rheumatoid Arthritis
por: Solomon, Daniel H, et al.
Publicado: (2013)

Increased primary care use for musculoskeletal symptoms, infections and comorbidities in the years before the diagnosis of inflammatory arthritis
por: van Beers-Tas, Marian, et al.
Publicado: (2020)

Non-participation in population-based disease prevention programs in general practice
por: Koopmans, Berber, et al.
Publicado: (2012)

Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial
por: van Boheemen, Laurette, et al.
Publicado: (2021)

The increased cardiovascular risk in rheumatoid arthritis: when does it start?
por: Nurmohamed, Michael T
Publicado: (2010)

The association between GP organisational factors and the effectiveness of a prevention programme for cardiometabolic diseases: a prospective intervention study
por: Badenbroek, Ilse F, et al.
Publicado: (2020)

Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022
por: Dijkshoorn, Bas, et al.
Publicado: (2022)

Cardiometabolic prevention consultation in the Netherlands: screening uptake and detection of cardiometabolic risk factors and diseases – a pilot study
por: Van der Meer, Victor, et al.
Publicado: (2013)

Cardiovascular disease risk in patients with inflammatory arthritis nowadays still substantially elevated
por: Raadsen, Reinder, et al.
Publicado: (2023)

Characteristics and motives of non-responders in a stepwise cardiometabolic disease prevention program in primary care
por: Badenbroek, Ilse F, et al.
Publicado: (2021)

Factors associated with variation in urgency of primary out-of-hours contacts in the Netherlands: a cross-sectional study
por: Zwaanswijk, Marieke, et al.
Publicado: (2015)

Use of out-of-hours primary care in affluent and deprived neighbourhoods during reforms in long-term care: an observational study from 2013 to 2016
por: Jansen, Tessa, et al.
Publicado: (2019)

Variability in quantitative analysis of atherosclerotic plaque inflammation using (18)F-FDG PET/CT
por: Lensen, Karel-Jan D. F., et al.
Publicado: (2017)

Mapping non-response in a prevention program for cardiometabolic diseases in primary care: How to improve participation?
por: Badenbroek, Ilse F., et al.
Publicado: (2020)

Different inflammatory pathways underlying cardiovascular risk in secondary prevention( )
por: Nurmohamed, Nick S, et al.
Publicado: (2022)

Design of the INTEGRATE study: effectiveness and cost-effectiveness of a cardiometabolic risk assessment and treatment program integrated in primary care
por: Badenbroek, Ilse F, et al.
Publicado: (2014)

Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice
por: Agca, Rabia, et al.
Publicado: (2022)

Erratum to: Design of the INTEGRATE study: effectiveness and cost-effectiveness of a cardiometabolic risk assessment and treatment program integrated in primary care
por: Badenbroek, Ilse F, et al.
Publicado: (2016)

Role of inflammatory factors and adipose tissue in pathogenesis of rheumatoid arthritis and osteoarthritis. Part II: Inflammatory background of osteoarthritis
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2013)

Cardiovascular risk in persons at risk of developing rheumatoid arthritis
por: van Boheemen, Laurette, et al.
Publicado: (2020)

Estimating Morbidity Rates Based on Routine Electronic Health Records in Primary Care: Observational Study
por: Nielen, Mark M J, et al.
Publicado: (2019)

Cardiovascular Risk in Systemic Inflammatory Arthritis
por: Atzeni, Fabiola, et al.
Publicado: (2023)

Prevalence and severity of periodontitis in patients with established rheumatoid arthritis and osteoarthritis
por: Disale, Pooja R., et al.
Publicado: (2020)

Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus
por: van den Oever, Inge A. M., et al.
Publicado: (2010)

Implementation of selective prevention for cardiometabolic diseases; are Dutch general practices adequately prepared?
por: Stol, Daphne M., et al.
Publicado: (2018)

Uptake and detection rate of a stepwise cardiometabolic disease detection program in primary care—a cohort study
por: Stol, Daphne M, et al.
Publicado: (2020)

Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment
por: Choy, Ernest, et al.
Publicado: (2014)

Antirheumatic drugs for cardiovascular disease prevention: the case for colchicine
por: Lems, Willem, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5r5t8jpt5gq9i18c3ln25fs9rk